As of Feb 27
| -0.37 / -3.84%|
The 4 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 19.50, with a high estimate of 33.00 and a low estimate of 5.00. The median estimate represents a +110.36% increase from the last price of 9.27.
The current consensus among 5 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.